bioRxivMicrobiologyPreprint
Identification of essential oils with strong activity against stationary phase uropathogenic Escherichia coli
Abstract
Escherichia coli is the most dominant pathogen causing urinary tract infections (UTIs), but the current most frequently prescribed antibiotics do not always effectively cure the infection due to quiescent persister bacteria. While it has been reported that some essential oils have antimicrobial activity against growing E. coli, the activity of essential oils against the non-growing stationary phase E. coli which is enriched in persisters has not been investigated. We evaluated the activity of 140 essential oils against stationary phase uropathogenic E. coli UTI89 and identified 39, 8 and 3 essential oils at 0.5%, 0.25% and 0.125% concentrations to have high activity against stationary phase E. coli. Among the top eight essential oils, Oregano showed higher activity than the known persister drug tosufloxacin. The other top seven hits included Allspice, Bandit \"Thieves\", Cinnamon bark, Syzygium aromaticum, Health shield, Cinnamon leaf and Clove bud. In Oregano essential oil drug combination studies with common UTI antibiotics, Oregano plus quinolone drugs (tosufloxacin, levofloxacin, ciprofloxacin) completely eradicated all stationary phase E. coli cells, partially enhanced the activity of nitrofurantoin, but had no apparent enhancement for fosfomycin, meropenem and cefdinir. Our findings may facilitate development of more effective treatments for persistent UTIs.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of essential oils with activity against stationary phase Staphylococcus aureus
- The Burden of Antimicrobial Resistance among Urinary Tract Isolates of Escherichia coli in the United States in 2017
I. Critchley, N. Cotroneo, … R. Mendes·bioRxiv·Jul 17, 2019
- Antibacterial activity of a newly identified phage-derived endolysin and its parental bacteriophage against clinical uropathogenic Escherichia coli
Wojciech Wesołowski, Sylwia Bloch, … Bożena Nejman-Faleńczyk·bioRxiv·Sep 10, 2026
- Lysosomal activation in bladder epithelium enhances intracellular antibiotic clearance of uropathogenic Escherichia coli
Kathrin Tomasek, Kristina Skurvydaite, … John D. McKinney·bioRxiv·Oct 22, 2025
- High Activity Of Selective Essential Oils Against Stationary Phase Borrelia burgdorferi As A Persister Model
- In vitro activity of hydroxychloroquine in combination with antibiotics against intracellular uropathogenic Escherichia coli
Vincent Pargny, Nicolas Vautrin, … Kévin Alexandre·bioRxiv·Oct 13, 2024